Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(31 sites)

United States

University Of Colorado, Aurora, Colorado

Mayo Clinic Jacksonville, Jacksonville, Florida

Northwestern University, Chicago, Illinois

Massachusetts General Hospital, Boston, Massachusetts

Mayo Clinic Rochester, Rochester, Minnesota